Nktx stock forecast.

Nkarta, Inc. (NKTX) stock forecast and price target. Find the latest Nkarta, Inc. NKTX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Nktx stock forecast. Things To Know About Nktx stock forecast.

Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for Nkarta stock is $13, which predicts an increase of 392.42%. …NKTX | Oversold Healthcare Play | LONG Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific p Nkarta, Inc., a a clinical-stage biopharmaceutical ...Oct 11, 2023 · An investor can expect a potential return of 1007.01% based on the average NKTX price forecast. Analyzing the NKTX fundamentals To continue investigating profitability, this company’s Return on Assets is posted at -30.48, Equity is -36.53, Total Capital is -33.11, and Invested Capital is -31.98. The average Livent stock price prediction forecasts a potential upside of 45.25% from the current LTHM share price of $14.32. What is LTHM's forecast return on equity (ROE) for 2023-2025? (NYSE: LTHM) forecast ROE is N/A, which is considered weak.

2023-01-17. 3,691. $5.49. $20.26k Sell. 1 of 2. NKTX insiders have sold more... subscribe to Premium to read more. Net Insider Buy/Sell (L12M) Ownership. Be the first to know when NKTX insiders and whales buy or sell their stock. Get Free NKTX Updates.Analyst Price Forecast Suggests 852.85% Upside. As of June 2, 2023, the average one-year price target for Nkarta is 26.78. The forecasts range from a low of 18.18 to a high of $33.60. The average ...

NKTX Stock Predictions, Articles, and Nkarta Inc News ... NKTX stock is a fast mover, and a recent share-price bump came in the wake of exciting data from a "killer cell" anti-cancer research program.Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business.

Chief Financial & Business Officer exercised options and sold US$71k worth of stock Jul 28. Nkarta, Inc. Announces Executive Changes Jul 26. Price target decreased to US$43.56 Jul 18. ... NKTX is forecast to remain unprofitable over the next 3 years. Revenue vs Market: NKTX is forecast to have no revenue next year.Analyst projections state that NKTX is forecast to be at a low of $10.00 and a high of $25.00. In order for the stock price to hit the forecast high, the stock would need to plunge -972.96% from its current level, while the stock would need to crash -329.18% from its current level to reach the projected low. Nkarta Inc (NKTX) estimates and ...(See NKTX stock forecast) To find good ideas for penny stocks trading at attractive valuations, visit TipRanks’ Penny Stock Screener. Disclaimer: The opinions expressed in this article are ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.One of the most compelling stocks with 100% upside potential, NKTX nevertheless requires significant patience. Since the beginning of this year, shares plunged almost 22%. In the past 365 days ...

Oct 11, 2023 · An investor can expect a potential return of 1007.01% based on the average NKTX price forecast. Analyzing the NKTX fundamentals To continue investigating profitability, this company’s Return on Assets is posted at -30.48, Equity is -36.53, Total Capital is -33.11, and Invested Capital is -31.98.

Find the latest Evoke Pharma, Inc. (EVOK) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...

According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.Apple Inc () Stock Market info Recommendations: Buy or sell Apple stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Apple share forecasts, stock quote and buy / sell signals below.According to present data Apple's AAPL shares and potentially its market environment have been in a bullish cycle in the last 12 …0 Oppenheimer Downgrades Nkarta to Perform Best Analysts Covering Nkarta Most Accurate Analysts Most Profitable Analysts Which Analyst Should I Follow If I Want to …Oct. 18, 2023, 08:00 AM Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter: In the last 3 months, 7 analysts have offered 12 …Find real-time TMPO - Tempo Automation Holdings Inc stock quotes, company profile, news and forecasts from CNN Business.Nkarta, Inc. (NKTX) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. See Nkarta, Inc. (NKTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.IOBT Stock 12 Months Forecast. $9.00. (837.99% Upside) Based on 3 Wall Street analysts offering 12 month price targets for IO Biotech in the last 3 months. The average price target is $9.00 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 837.99% change from the last price of $0.96.

Nov 30, 2023 · What is Nkarta's Market Cap? ( NASDAQ: NKTX) Nkarta 's market cap is $127.10M, as of Nov 24, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Nkarta 's market cap is calculated by multiplying NKTX 's current stock price of $2.59 by NKTX 's total outstanding shares of. Of the 101 institutional investors that purchased Nkarta stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Deep Track Capital LP ($2.11M), State Street Corp ($2.05M), Wasatch Advisors LP ($1.98M), Braidwell LP ($1.53M), Price T Rowe Associates Inc. MD ($1.52M), Tang …Oct. 18, 2023, 08:00 AM Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter: In the last 3 months, 7 analysts have offered 12 …Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for Nkarta stock is $13, which predicts an increase of 392.42%. …According to the issued ratings of 7 analysts in the last year, the consensus rating for Nektar Therapeutics stock is Reduce based on the current 2 sell ratings, 4 hold ratings and 1 buy rating for NKTR. The average twelve-month price prediction for Nektar Therapeutics is $3.00 with a high price target of $6.00 and a low price target of $1.00.Nkarta is an oncology company that uses the innate capacities of natural killer cells to target tumors. Its current market cap is around 620 million. The below shows a chart of its share price ...Vertex Energy Inc () Stock Market info Recommendations: Buy or sell Vertex Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Vertex Energy share forecasts, stock quote and buy / sell signals below.According to present data Vertex Energy's VTNR shares and potentially its market environment have …

Nkarta Inc share price live 2.64, this page displays NASDAQ NKTX stock exchange data. View the NKTX premarket stock price ahead of the market session or assess the after hours quote. ... Raymond James Upgrades Nkarta Inc. to Strong Buy 'on Pivot to Autoimmune and AML Outlook' (Updated - October 17, 2023 3:19 PM EDT) Analysts at …

443,833.95. 393,471.41. 348,867.82. Trading Economics provides data for 20 million economic indicators from 196 countries including actual values, consensus figures, forecasts, historical time series and news. Stock Market Forecast 2023/2024 - was last updated on Friday, December 1, 2023. Trading Economics provides data for 20 million …Find the latest Sunshine Biopharma, Inc. (SBFM) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Apr 25, 2022 · On today's stock market, the biotech stock soared 140.9% to 18.72. After the close, Nkarta announced a public offering for $150 million shares of its common stock. Find the latest Gritstone bio, Inc. (GRTS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...This transaction had a minor impact of -0.01% on the firm's portfolio, with the shares being traded at a price of $2.03. Post-trade, T. Rowe Price Investment Management, Inc. (Trades, Portfolio ... Forecast. NKTX technical analysis. This gauge displays a real-time technical ... Stock Screener · Forex Screener · Crypto Pairs Screener · Crypto Coins Screener ...Nov 27, 2023 · According to the issued ratings of 5 analysts in the last year, the consensus rating for Nkarta stock is Buy based on the current 1 hold rating, 3 buy ratings and 1 strong buy rating for NKTX. The average twelve-month price prediction for Nkarta is $14.67 with a high price target of $26.00 and a low price target of $9.00. Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $68.19M. -89.4%. Market Cap / Employee. The market cap of a ...

Find real-time GSK - GSK plc stock quotes, company profile, news and forecasts from CNN Business.

Next reporting date. February 14, 2024. EPS forecast (this quarter) $0.29. Annual revenue (last year) $11.1B. Annual profit (last year) $432.0M. Net profit margin.

Find the latest Nkarta, Inc. (NKTX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.Nkarta has generated ($2.50) earnings per share over the last year ( ($2.50) diluted earnings per share). Earnings for Nkarta are expected to grow in the coming year, from ($2.50) to ($2.42) per share. Nkarta has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 21st, 2024 ...Based on 10 Wall Street analysts offering 12 month price targets for Livent in the last 3 months. The average price target is $25.30 with a high forecast of $35.00 and a low forecast of $19.00. The average price target represents a 84.00% change from the last price of $13.75. Highest Price Target $35.00. Average Price Target $25.30.Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Find the latest Gritstone bio, Inc. (GRTS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...According to . 4 Wall Street analysts that have issued a 1 year NKTX price target, the average NKTX price target is $11.75, with the highest NKTX stock price forecast at $15.00 and the lowest NKTX stock price forecast at $9.00.Preliminary cancer treatment data is pushing the stock higher today. Nkarta (NASDAQ: NKTX) stock is rocketing higher on Monday after the company released preliminary data from a Phase 1 clinical ...On June 22, six executives sold a total of 4,033 shares of Nkarta, including CEO Paul Hastings, who sold 1,704. While company insiders often sell stock for various reasons, the timing of the sales ...Nov 30, 2023 · A high-level overview of Nkarta, Inc. (NKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

We would like to show you a description here but the site won’t allow us.In 2022, GSK plc's revenue was 29.32 billion, an increase of 18.74% compared to the previous year's 24.70 billion. Earnings were 14.96 billion, an increase of 241.07%. Financial numbers in GBP Financial Statements.Price Target Based on short-term price targets offered by seven analysts, the average price target for Nkarta, Inc. comes to $12.57. The forecasts range from a low of $9.00 to a high of $15.00....Instagram:https://instagram. carbon accounting software marketsewer line insurancecancer insurance no waiting periodjp morgan wealth plan Nkarta (NKTX) Company Description: Nkarta Inc is a bio-pharmaceutical company focused on the discovery, development and commercialization of engineered, allogeneic, and off-the-shelf cell ...The average price target for Macy's is $14.83. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $19.00 ,the lowest forecast is $10.00. The average price target represents -0.07% Decrease from the current price of $14.84. headless cms market sizewhere to invest in startups Find the latest Gamida Cell Ltd. (GMDA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ... mortgage companies in north carolina Find real-time BEAM - Beam Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.20.57%. NKTX | Complete Nkarta Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.